2012 Cohort Consortium Symposium
When Bigger is Better: Combining and Designing Cohorts for Power

When Bigger is Better: Combining and Designing Cohorts for Power
October 25, 2012
Natcher Conference Center
Bethesda, Maryland

Overview

The Cohort Consortium is an extramural-intramural partnership formed by the National Cancer Institute (NCI) to address the need for large-scale collaborations to pool the large quantity of data and biospecimens necessary to conduct a wide range of cancer studies. The Consortium includes investigators responsible for more than 40 high-quality cohorts involving more than 4 million people. Through its collaborative network of investigators, the Consortium provides a coordinated, interdisciplinary approach to tackling important scientific questions, economies of scale, and opportunities to quicken the pace of research. The Symposium will focus on accomplishments of the Cohort Consortium and presentations of experiences across different NIH Institutes in combining and designing cohorts for power.

[Return to Top]

Purpose

The Cohort Consortium Symposium was jointly sponsored by the Epidemiology and Genomics Research Program (EGRP) of the NCI's Division of Cancer Control and Population Sciences (DCCPS), and the NCI's Division of Cancer Epidemiology and Genetics (DCEG). The objectives of the Symposium were to:

[Return to Top]

Agenda

Time Topic
7:30 a.m. - 8:30 a.m. Registration
Session I Opening Session
8:30 a.m. - 8:40 a.m. Welcome Remarks (DCCPS)

Muin Khoury, M.D., Ph.D.
Associate Director (Acting), Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
8:40 a.m. - 8:50 a.m. Overview and goals of the Symposium

James R. Cerhan, M.D., Ph.D.
Chair, Cohort Consortium Secretariat
Professor and Chair, Division of Epidemiology
Mayo Clinic College of Medicine
8:50 a.m. - 9:05 a.m. Recent accomplishments of Cohort Consortium

Patricia Hartge, Sc.D.
Deputy Director, Epidemiology and Biostatistics Program
Division of Cancer Epidemiology and Genetics
National Cancer Institute
Session II Spectrum of Experiences in Combining and Designing Cohorts for Power

Moderator: Deborah M. Winn, Ph.D.
Deputy Director, Division of Cancer Control and Population Sciences National Cancer Institute
9:05 a.m. - 9:15 a.m. National Cancer Institute (NCI) - New Initiatives
(Funding of Atherosclerosis Risk in Communities Study for cancer, survivorship, and sequencing)

Deborah M. Winn, Ph.D.
Deputy Director, Division of Cancer Control and Population Sciences National Cancer Institute
9:15 a.m. - 9:45 a.m. National Human Genome Research Institute Perspective and Examples

Lucia Hindorff, Ph.D., M.P.H.
Epidemiologist, Office of Population Genomics
National Human Genome Research Institute

Adam Felsenfeld, Ph.D.
Program Director, Division of Extramural Research
National Human Genome Research Institute
9:45 a.m. - 10:15 a.m. National Heart, Lung, and Blood Institute (NHLBI) - Perspective and examples

Diane Bild, M.D., M.P.H.
Associate Director, Prevention and Population Sciences Program
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute
10:15 a.m. - 10:45 a.m. National Institute on Aging (NIA) - Perspective and examples

Richard M. Suzman, Ph.D.
Director, Behavioral and Social Research Program
National Institute on Aging
10:45 a.m. - 11:00 a.m. Break
Session III Reflection and Discussion

Moderator: James R. Cerhan, M.D., Ph.D.
Chair, Cohort Consortium Secretariat
Professor and Chair, Division of Epidemiology
Mayo Clinic College of Medicine
11:00 a.m. - 12:15 p.m. Robert T. Croyle, Ph.D.
Director, Division of Cancer Control and Population Sciences
National Cancer Institute

Robert N. Hoover, M.D., Sc.D.
Director, Epidemiology and Biostatistics Program
Division of Cancer Epidemiology and Genetics
National Cancer Institute

Julie E. Buring, Sc.D.
Professor of Medicine, Brigham and Women's Hospital / Harvard Medical School
Professor of Epidemiology, Harvard School of Public Health

William J. Blot, Ph.D.
Professor of Medicine, Vanderbilt University
Chief Executive Officer, International Epidemiology Institute, Ltd.

Stephen Chanock, M.D.
Chief, Laboratory of Translational Genomics
Director, Core Genotyping Facility
Division of Cancer Epidemiology and Genetics
National Cancer Institute
12:15 p.m. End of Symposium

[Return to Top]

Videocast

Those who were unable to participate in person may view an NIH videocastExternal Web Site Policy of the Symposium.

[Return to Top]

[Return to Top]

Planning Committee

[Return to Top]

Contact

For further information or questions about the Symposium, contact Nonye Harvey, M.P.H. or visit the Cohort Consortium website.

[Return to Top]

Last Updated: 15 Jan 2013

Division of Cancer Control and Population Sciences National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov